Investing
FTC Commissioners yet to meet on Amgen-Horizon deal – CNBC
© Reuters. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/
(Reuters) – Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen (NASDAQ:)’s acquisition of Horizon Therapeutics (NASDAQ:), CNBC reported on Tuesday.
The news comes a day after reports that the FTC is expected to file a lawsuit as early as Tuesday to block the $27.8 billion deal.
Read the full article here
-
Passive Income6 days ago
The One Microsoft Design Tool Business Owners Shouldn’t Miss
-
Side Hustles4 days ago
The DOJ Reportedly Wants Google to Sell Its Chrome Browser
-
Investing5 days ago
This Founder Turned a Hangover Cure into Millions
-
Side Hustles4 days ago
How to Create a Unique Value Proposition (With Tips & Examples)
-
Investing6 days ago
Your Firsthand Experiences Shape the Way You Run Your Business — Here’s How Mine Shaped Me
-
Investing3 days ago
Are You Missing These Hidden Warning Signs When Hiring?
-
Investing4 days ago
Barbara Corcoran, Lori Greiner Differ on ‘Quiet Vacationing’
-
Make Money3 days ago
7 Common Things You Should Never Buy New